INTERNATIONAL PATENT: NEKTAR THERAPEUTICS, BIOLOJIC DESIGN LTD. FILES APPLICATION FOR "ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) ANTIBODIES AND METHODS OF USE"

GENEVA, Dec. 10 -- NEKTAR THERAPEUTICS (455 Mission Bay Blvd. South, Suite 100San Francisco, CA 94158), BIOLOJIC DESIGN LTD. (6 Ilan Ramon St., 3rd Floor7403639 Ness Ziona) filed a patent application (PCT/US2025/031275) for "ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) ANTIBODIES AND METHODS OF USE" on May 28, 2025. With publication no. WO/2025/250701, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAMEL, Damon Justin (c/o Nektar Therapeutics455 Mission Bay Blvd. South, Suite 100San Francisco, CA 94158), MIYAZAKI, Takah...